Sleep Health EnergyImprove Your Sleep, Health & Energy

Cannabis for Autism Spectrum Disorder: What the Research Shows

By Sleep Health Energy Team · · Updated

a psychologist's session with an autistic boy
Contents

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition that profoundly impacts individuals’ social interactions, communication skills, and behavior patterns.

While traditional treatments and therapies exist, researchers are actively exploring alternative approaches to help alleviate symptoms and enhance the quality of life for individuals with ASD.

One area under study is cannabis, especially cannabidiol (CBD). This article looks at what the research shows so far, the legal status of medical cannabis, and the risks.

Cannabis is not a proven treatment for autism. Any decision about it belongs with the person's own clinician.

Understanding Autism Spectrum Disorder

Autism Spectrum Disorder encompasses a wide range of symptoms, including challenges in social interaction, repetitive behaviors, and difficulties with verbal and nonverbal communication.

The severity of symptoms can vary significantly, necessitating various levels of support for individuals with ASD. Traditional treatments often involve therapies such as applied behavior analysis (ABA), speech therapy, and occupational therapy, aimed at improving communication skills, social interactions, and daily functioning.

The Science Behind Cannabis

Cannabis, a plant with a long history of medicinal use, contains compounds known as cannabinoids. Two well-known cannabinoids are cannabidiol (CBD) and tetrahydrocannabinol (THC). While CBD is non-intoxicating and has gained attention for its potential therapeutic benefits, THC is responsible for the psychoactive effects commonly associated with cannabis.

Cannabis leaf on a sunset background

Cannabis and Autism: The Connection

Emerging research suggests that cannabis may have a role in managing ASD symptoms. The human body has an endocannabinoid system (ECS), which regulates various physiological processes, including mood, pain perception, and immune response.

Some lab and early human studies suggest the ECS may work differently in some people with ASD. This idea is still a hypothesis, not an established cause of autism.

Preliminary research and anecdotal evidence indicate that certain cannabinoids, particularly CBD, may interact with the ECS to potentially alleviate some of the symptoms associated with ASD.

These symptoms may include anxiety, sleep disturbances, hyperactivity, and repetitive behaviors. The evidence is thin, though.

A 2024 systematic review of cannabinoids for core autism symptoms in children and adolescents found only five studies. Most of the reported effects were not statistically significant, and most studies had a high risk of bias.

Adults in the UK who want to discuss prescribed cannabis can explore options like Alternaleaf, a medical cannabis clinic, which offers consultations about cannabis-based medicines for conditions such as anxiety, stress, and depression. Whether a prescription is appropriate is a clinical decision.

The legal status of cannabis varies across jurisdictions. In the United States, individual states have the authority to regulate cannabis, resulting in a patchwork of different laws and regulations. Take Georgia as an example. Marijuana is not legal there, but the state runs a limited Medical Cannabis Patient Registry for low-THC products.

Qualifying conditions include autism spectrum disorder diagnosed at age 18 or older, or severe autism in patients under 18. A Georgia-licensed physician must certify the patient, which is the step behind getting a medical marijuana card in Georgia.

The FDA has not approved cannabis for autism. Its only approved CBD drug, Epidiolex, treats seizures linked to a few rare forms of epilepsy.

Risks and Side Effects of Cannabis in ASD Treatment

While researchers are studying cannabis for ASD, it is crucial to acknowledge the potential risks and side effects associated with its use. Some individuals may experience drowsiness, dizziness, changes in appetite, or dry mouth. The FDA also notes that CBD can affect the liver and interact with other medicines.

Additionally, the psychoactive effects of THC can impact cognitive function and may not be suitable for all individuals with ASD. THC is a particular concern for children and teens, whose brains are still developing. Talk with the person's pediatrician, psychiatrist, or other treating clinician before trying any cannabis product.

Future Research and Implications

Research on cannabis for ASD is still in its early stages, and further research is necessary to establish its safety, efficacy, and optimal dosing protocols.

Ongoing studies, clinical trials, and observational research are needed to provide a more comprehensive understanding of the potential benefits and limitations of cannabis in treating ASD.

Successful research in this field could have transformative implications, offering individuals with ASD and their families a new avenue of support and symptom management. It is crucial for the scientific and medical communities to continue exploring the potential of cannabis while adhering to rigorous research protocols and ethical considerations.

Conclusion

Cannabis, and CBD in particular, is an active research area for autism. So far, the studies are small and mixed, and cannabis is not an approved or proven autism treatment.

The evolving legal landscape surrounding medical cannabis underscores the changing attitudes toward its medical applications. Approaching the use of cannabis for ASD treatment requires caution, with the consultation of healthcare professionals and adherence to legal and safety guidelines.

Evidence-based therapies remain the foundation of autism care. Larger, well-designed trials will show whether cannabis has a place alongside them.

Sources